Resistance analysis in the phase III COMET-TAIL study: treatment of COVID-19 with intramuscular or intravenous sotrovimab

Category Primary study
JournalFuture Virol.
Year 2024
This article has no abstract
Epistemonikos ID: aaa2c101325d24282f660887f2ef7c7e8db84262
First added on: Jul 04, 2024